OVARIAN CANCER RECURRENT
Clinical trials for OVARIAN CANCER RECURRENT explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CANCER RECURRENT trials appear
Sign up with your email to follow new studies for OVARIAN CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Smart Bomb' drug trial offers hope for women with recurrent ovarian cancer
Disease control Recruiting nowThis study is testing a new targeted cancer drug called raludotatug deruxtecan in women whose ovarian cancer has returned after previous chemotherapy. The drug works like a 'smart bomb' that attaches to cancer cells and delivers treatment directly to them. Researchers want to fin…
Matched conditions: OVARIAN CANCER RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Personalized immune cells engineered to fight tough ovarian cancer
Disease control Recruiting nowThis early-stage trial is testing a new personalized cell therapy called OPB-101 for women with ovarian cancer that has stopped responding to standard platinum-based chemotherapy. Doctors will modify a patient's own immune cells in a lab to target the cancer and then infuse them …
Matched conditions: OVARIAN CANCER RECURRENT
Phase: PHASE1 • Sponsor: Outpace Bio, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for ovarian cancer patients: experimental antibody aims to keep cancer at bay
Disease control Recruiting nowThis trial is testing whether an experimental antibody called COM701 can help control ovarian cancer that has returned after previous treatment. The study will involve 60 participants with relapsed platinum-sensitive ovarian cancer who will receive either COM701 or a placebo thro…
Matched conditions: OVARIAN CANCER RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Compugen Ltd • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC